Hiroshi Soda

Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer Cells

Shigeru Kawabata, Mikio Oka, Ken Shiozawa et al. · Biochemical and Biophysical Research Communications · 2001 · 239 citations

Medicine, Molecular Biology, Oncology +12

Irinotecan (CPT-11) and Characteristic Mucosal Changes in the Mouse Ileum and Cecum

Nobuhiro Ikuno, Hiroshi Soda, Masahiko Watanabe et al. · JNCI Journal of the National Cancer Institute · 1995 · 188 citations

Medicine, Pathology, Pharmacology +16

Transport of 7-Ethyl-10-hydroxycamptothecin (SN-38) by Breast Cancer Resistance Protein ABCG2 in Human Lung Cancer Cells

Katsumi Nakatomi, Megumi Yoshikawa, Mikio Oka et al. · Biochemical and Biophysical Research Communications · 2001 · 188 citations

Medicine, Molecular Biology, Pharmacology +12

Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells

Takeshi Kitazaki, Mikio Oka, Yoichi Nakamura et al. · Lung Cancer · 2005 · 179 citations

Medicine, Oncology, Pharmacology +13

Gefitinib (“Iressa”, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses Breast Cancer Resistance Protein/ABCG2–Mediated Drug Resistance

Yoichi Nakamura, Mikio Oka, Hiroshi Soda et al. · Cancer Research · 2005 · 177 citations · Full text

Medicine, Oncology, Pharmacology +15